Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation & Amortization (IS)Gross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Anterix (ATEX) Shares Issued (2017 - 2025)

Anterix filings provide 12 years of Shares Issued readings, the most recent being $157000.0 for Q3 2025.

  • On a quarterly basis, Shares Issued fell 54.23% to $157000.0 in Q3 2025 year-over-year; TTM through Dec 2025 was $1.8 million, a 32.31% decrease, with the full-year FY2025 number at $3.7 million, up 369.88% from a year prior.
  • Shares Issued hit $157000.0 in Q3 2025 for Anterix, down from $1.7 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $5.4 million in Q2 2021 to a low of $7000.0 in Q2 2023.
  • Median Shares Issued over the past 5 years was $1.1 million (2022), compared with a mean of $1.7 million.
  • Biggest five-year swings in Shares Issued: plummeted 99.2% in 2023 and later surged 23000.0% in 2024.
  • Anterix's Shares Issued stood at $3.6 million in 2021, then tumbled by 75.9% to $872000.0 in 2022, then plummeted by 99.2% to $7000.0 in 2023, then surged by 4800.0% to $343000.0 in 2024, then tumbled by 54.23% to $157000.0 in 2025.
  • The last three reported values for Shares Issued were $157000.0 (Q3 2025), $1.7 million (Q1 2025), and $343000.0 (Q3 2024) per Business Quant data.